Wow...wonder what this might have cost...or what alternatives were in the agreement to protect Nexium from having a generic equivalent made in India? Now the date is in the year 2014 before a generic will be available...but there's still the generic copy of Protronix from Wyeth to arrive...another heartburn drug...BD
LONDON — Shares in the pharmaceutical company AstraZeneca soared Tuesday on news that an agreement with an Indian company would delay the release of a generic competitor to its best-selling heartburn drug for six years.
AstraZeneca said financial guidance for 2008 would remain unchanged, but the company’s shares shot up more than 7 percent in London as analysts sensed less of a profit risk for the company, which is based in London.
AstraZeneca in Pact With Rival to Delay a Generic Drug - New York Times
0 comments :
Post a Comment